DIVISLAB vs SUNPHARMA
Head-to-head DCF comparison · Divi's Laboratories Limited vs Sun Pharmaceutical Industries
Model Favors
SUNPHARMA shows a larger model margin of safety
Leads on 4 of 4model metrics · not investment advice
DIVISLAB
Divi's Laboratories Limited
Pharma
₹6,639
Above Fair ValueSUNPHARMA
Sun Pharmaceutical Industries
Pharma
₹1,786
Near Fair Value| Metric | DIVISLAB | SUNPHARMA |
|---|---|---|
| Verdict | Above Fair Value | Near Fair Value |
| YieldIQ Score | 40/100 | 53/100 |
| Fair Value | ₹2,481 | ₹1,346 |
| Current Price | ₹6,639 | ₹1,786 |
| Discount to FV | -62.6% | -24.6% |
| Moat | None | Moderate |
| Piotroski F-Score | 5/9 | 6/9 |
| ROE | 15.3% | 13.7% |
| Debt / Equity | 0.00 | 0.03 |
| EV / EBITDA | 46.1× | 23.0× |
| Market Cap | ₹1.76 Lakh Cr | ₹4.29 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.